Filing Details

Accession Number:
0001181431-13-059672
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-11-19 17:26:23
Reporting Period:
2013-11-15
Filing Date:
2013-11-19
Accepted Time:
2013-11-19 17:26:23
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1415336 Zeltiq Aesthetics Inc ZLTQ Electromedical & Electrotherapeutic Apparatus (3845) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1562195 Carl Lamm 4698 Willow Road
Pleasanton CA 94588
Vp Of Operations No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2013-11-15 1,403 $16.37 17,443 No 4 F Direct
Common Stock Disposition 2013-11-18 2,347 $15.41 15,096 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 F Direct
No 4 S Direct
Footnotes
  1. Represents the number of shares withheld by and surrendered to the Issuer on November 15, 2013, to satisfy tax withholding obligations that arose in connection with the vesting of the RSU grant on November15, 2012 of 15,000 shares. The initial grant vested 25% on November 15, 2013 and the remaining shall vest annually at a rate of 25% per year, subject to the Report Person's continued service to the Issuer.
  2. The sales reported in this FORM 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on August 29, 2013.
  3. The initial RSU grant for 15,000 shares vest in four equal annual installments, of which the first installment vested on November 15, 2013.
  4. The price reported in Column for is an average price. These shares were sold in multiple transactions at prices ranging from $15.31-$15.52 inclusive. The Reporting Person undertakes to provide to ZELTIQ Aesthetics, Inc., any security holder of ZELTIQ Aesthetics, inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this FORM 4.